Patents by Inventor Sean D. McAllister

Sean D. McAllister has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RESORCINOL-BASED COMPOUNDS AND USES THEREOF
    Publication number: 20240059646
    Abstract: The disclosure provides for resorcinol-based compounds, pharmaceutical compositions made therefrom, and methods of treatment thereof for various disorders, including neoplastic disorders.
    Type: Application
    Filed: December 16, 2021
    Publication date: February 22, 2024
    Inventors: Sean D. McAllister, Pierre-Yves Desprez, Anuradha Mahadevan, Ravi K. Ujjinamatada
  • Methods and compositions for treating cancer
    Patent number: 11344527
    Abstract: This disclosure provides compositions and method useful for treating cell proliferative disorders including cancer. The disclosure provides cannabidiol derivatives and compositions thereof either alone or in combination with THC or a derivative thereof.
    Type: Grant
    Filed: November 8, 2013
    Date of Patent: May 31, 2022
    Assignee: Sutter Bay Hospitals
    Inventors: Sean D. McAllister, Pierre-Yves Desprez
  • Methods and compositions for treating cancer
    Patent number: 11260043
    Abstract: This disclosure provides compositions and method useful for treating cell proliferative disorders including cancer. The disclosure provides cannabidiol derivatives and compositions thereof either alone or in combination with THC or a derivative thereof.
    Type: Grant
    Filed: December 31, 2014
    Date of Patent: March 1, 2022
    Assignee: SUTTER BAY HOSPITALS
    Inventors: Sean D. McAllister, Pierre-Yves Desprez
  • Resorcinol derivatives
    Patent number: 10202322
    Abstract: The disclosure relates to cannabinoid derivative compounds, pharmaceutical compositions made thereof, and methods for treating various diseases and disorders including cancer.
    Type: Grant
    Filed: November 1, 2017
    Date of Patent: February 12, 2019
    Assignee: Sutter Bay Hospitals
    Inventors: Sean D. McAllister, Pierre-Yves Desprez, Anuradha Mahadevan
  • RESORCINOL DERIVATIVES
    Publication number: 20180170846
    Abstract: The disclosure relates to cannabinoid derivative compounds, pharmaceutical compositions made thereof, and methods for treating various diseases and disorders including cancer.
    Type: Application
    Filed: November 1, 2017
    Publication date: June 21, 2018
    Inventors: Sean D. McAllister, Pierre-Yves Desprez, Anuradha Mahadevan
  • Cannabidinoid derivatives
    Patent number: 9809521
    Abstract: The disclosure relates to cannabinoid derivative compounds, pharmaceutical compositions made thereof, and methods for treating various diseases and disorders including cancer.
    Type: Grant
    Filed: January 25, 2016
    Date of Patent: November 7, 2017
    Assignee: SUTTER WEST BAY HOSPITALS
    Inventors: Sean D. McAllister, Pierre-Yves Desprez, Anuradha Mahadevan
  • CANNABIDINOID DERIVATIVES
    Publication number: 20160376211
    Abstract: The disclosure relates to cannabinoid derivative compounds, pharmaceutical compositions made thereof, and methods for treating various diseases and disorders including cancer.
    Type: Application
    Filed: January 25, 2016
    Publication date: December 29, 2016
    Inventors: Sean D. McAllister, Pierre-Yves Desprez, Anuradha Mahadevan
  • Resorcinol derivatives
    Patent number: 9254272
    Abstract: The disclosure relates to cannabinoid derivative compounds, pharmaceutical compositions made thereof, and methods for treating various diseases and disorders including cancer.
    Type: Grant
    Filed: November 30, 2012
    Date of Patent: February 9, 2016
    Assignee: Sutter West Bay Hospitals
    Inventors: Sean D. McAllister, Pierre-Yves Desprez, Anuradha Mahadevan
  • METHODS AND COMPOSITIONS FOR TREATING CANCER
    Publication number: 20150320720
    Abstract: This disclosure provides compositions and method useful for treating cell proliferative disorders including cancer. The disclosure provides cannabidiol derivatives and compositions thereof either alone or in combination with THC or a derivative thereof.
    Type: Application
    Filed: July 17, 2015
    Publication date: November 12, 2015
    Applicant: Sutter West Bay Hospitals
    Inventors: Sean D. McAllister, Pierre-Yves Desprez
  • Methods and compositions for treating cancer
    Patent number: 9084771
    Abstract: This disclosure provides compositions and method useful for treating cell proliferative disorders including cancer. The disclosure provides cannabidiol derivatives and compositions thereof either alone or in combination with THC or a derivative thereof.
    Type: Grant
    Filed: May 16, 2008
    Date of Patent: July 21, 2015
    Assignee: Sutter West Bay Hospitals
    Inventors: Sean D. McAllister, Pierre-Yves Desprez
  • METHODS AND COMPOSITIONS FOR TREATING CANCER
    Publication number: 20150150844
    Abstract: This disclosure provides compositions and method useful for treating cell proliferative disorders including cancer. The disclosure provides cannabidiol derivatives and compositions thereof either alone or in combination with THC or a derivative thereof.
    Type: Application
    Filed: December 31, 2014
    Publication date: June 4, 2015
    Inventors: Sean D. McAllister, Pierre-Yves Desprez
  • METHODS AND COMPOSITIONS FOR TREATING CANCER
    Publication number: 20140065243
    Abstract: This disclosure provides compositions and method useful for treating cell proliferative disorders including cancer. The disclosure provides cannabidiol derivatives and compositions thereof either alone or in combination with THC or a derivative thereof.
    Type: Application
    Filed: November 8, 2013
    Publication date: March 6, 2014
    Inventors: Sean D. McAllister, Pierre-Yves Desprez
  • METHODS AND COMPOSITIONS FOR TREATING CANCER
    Publication number: 20100204312
    Abstract: This disclosure provides compositions and method useful for treating cell proliferative disorders including cancer. The disclosure provides cannabidiol derivatives and compositions thereof either alone or in combination with THC or a derivative thereof.
    Type: Application
    Filed: May 16, 2008
    Publication date: August 12, 2010
    Applicant: CALIFORNIA PACIFIC MEDICAL CENTER
    Inventors: Sean D. McAllister, Pierre-Yves Desprez